Verification of XAPPORT: a decision support app for physicians used for patients anticoagulated with rivaroxaban in terms of anticoagulation Management in elective surgery: verification process of medical decision algorithm (VeriXAPPORT)
This study shall determine whether XAPPORT – a mobile device app based on different guidelines, the summary of product characteristics of rivaroxaban, and clinical facts and practice – provides adequate guidance to physicians attending patients undergoing elective surgery, who have to interrupt treatment with rivaroxaban for surgery, in deciding how to approach the pre- and postoperative management of anticoagulation.
- Female or male patient ≥18 years who provided signed and dated informed consent to the use of their medical data - Patient was treated with rivaroxaban before and after surgery because of non-valvular atrial fibrillation (NVAF) or venous thromboembolism/pulmonary embolism (VTE/PE) - Elective surgery in a department of General Surgery or Orthopedics / Trauma Surgery was performed within the last 12 months before study start - The patient has been discharged from hospital - Patient’s medical records are available for data entry
- Patient participated in an interventional drug study within 3 months prior to the surgery and discharge from hospital
VeriXAPPORT: Verification of XAPPORT: a decision support app for physicians used for patients anticoagulated with rivaroxaban in terms of anticoagulation management in elective surgery: verification process of medical decision algorithm